Skip to main navigation
about geron
leadership
our culture & values
life at geron
careers
Partnerships
responsibility
focus areas
LR-Myelodysplastic Syndromes (LR-MDS)
Myelofibrosis (MF)
glossary of terms
our medicine
our science
telomerase inhibition
clinical trials
investigator-sponsored research
real-world evidence
publications & posters
patients & families
patient stories
advocacy & support
expanded access
news
press releases
events
investors
News & Events
News Releases
Events & Presentations
Publications
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Financials
SEC filings
Quarterly Results
Annual Reports
Governance
Documents & Charters
Board of Directors
Management Team
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact Us
careers
contact
about geron
leadership
our culture & values
life at geron
careers
Partnerships
responsibility
focus areas
LR-Myelodysplastic Syndromes (LR-MDS)
Myelofibrosis (MF)
glossary of terms
our medicine
our science
telomerase inhibition
clinical trials
investigator-sponsored research
real-world evidence
publications & posters
patients & families
patient stories
advocacy & support
expanded access
news
press releases
events
investors
News & Events
News Releases
Events & Presentations
Publications
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Analyst Coverage
Financials
SEC filings
Quarterly Results
Annual Reports
Governance
Documents & Charters
Board of Directors
Management Team
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact Us
careers
contact
Unsubscribe from all Geron Corporation email alerts
Investor FAQs
Email Alerts
Contact Us
Unsubscribe from all Geron Corporation email alerts
Email Address
Leave this field blank
Investor Contact
investor@geron.com
Media Relations
media@geron.com
Subscribe to Email Alerts
Email
*
Submit
